Table 2 Clinicopathological characteristics of the cohort included in the study (n = 213)
Characteristic | Control cohort | Cancer cohort |
|---|---|---|
n = 136 | n = 77 | |
Age (years) | ||
Mean (range) | 50.4 (23–88) | 66.4 (47–86) |
Sex, no. (%) | ||
Male | 72 (52.9) | 65 (84.4) |
Female | 64 (47.1) | 12 (15.6) |
Ethnicity, no. (%) | ||
Caucasian | 100 (73.5) | 74 (96.1) |
Asian | 22 (16.2) | 2 (2.6) |
African-American | 3 (2.2) | 0 (0) |
Hispanic | 1 (0.7) | 1 (1.3) |
Other | 0 (0) | 0 (0) |
Not available | 10 (7.4) | 0 (0) |
Tumor type, no. (%) | ||
NMIBC, TCC | n.a | 66 (85.7) |
MIBC, TCC | n.a | 10 (13.0) |
AC | n.a | 1 (1.3) |
SCC | n.a | 0 (0) |
Tumor grade, no. (%) | ||
Low grade | n.a | 10 (13.0) |
High grade | n.a | 51 (66.2) |
Not Available | n.a | 16 (20.8) |